BRIEF-Gemini reports Q1 net loss per share of $0.04
* Now expecting revenue for 2017 to be less than 2016 but expects activity to pick up in second half of 2017 into 2018 Source text for Eikon: Further company coverage:
Oct 18 Johnson & Johnson reported a 4.2 percent increase in quarterly revenue, fueled by strong sales in its prescription drugs business.
The company's net earnings rose to $4.27 billion, or $1.53 per share, in the third quarter, from $3.36 billion, or $1.20 per share, a year earlier.
Sales rose to $17.82 billion from $17.10 billion.
(Reporting by Natalie Grover in Bengaluru; Editing by Sriraj Kalluvila)
* Ironhorse announces Q1 2017 financial and operating results
* AT&T announces IBEW-represented employees vote to ratify midwest wireline agreement